BioCentury
ARTICLE | Distillery Techniques

Drug platforms

May 8, 2017 7:10 PM UTC

An in vitro differentiation protocol could generate V2a interneurons from HPSCs for use as cell therapies to treat SCI. The protocol had three steps: treating HPSCs with two tool compounds that inhibi...

BCIQ Company Profiles

Gladstone Institutes

BCIQ Target Profiles

Sonic hedgehog homolog (SHH)